MedTrace Logo

Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant Prescriptions

NCT02898090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1213

Last updated 2024-03-27

No results posted yet for this study

Summary

This research focuses on the development and validation of indicators on the appropriateness of oral anticoagulant prescriptions. The investigators want to propose transferable tools to other healthcare institutions to allow automated construction of indicators as part of a structured approach to improve future practices. The main objective of the study is to develop indicators on the appropriateness of oral anticoagulant prescriptions in adult medicine automated from the hospital information system and to assess their criterion validity.

Conditions

  • Healthcare Quality Indicators
  • Inappropriate Prescribing
  • Anticoagulant Drugs
  • Atrial Fibrillation
  • Venous Thromboembolism
  • Valvular Heart Disease
  • Brain Injury

Sponsors & Collaborators

  • Ministry for Health and Solidarity, France

    collaborator OTHER_GOV

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Aurélie PETIT-MONEGER, MD · University Hospital Bordeaux, France

  • Florence SAILLOUR-GLENISSON, MD · University Hospital Bordeaux, France

  • Frantz THIESSARD, MD · University Hospital Bordeaux, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-28
Primary Completion
2022-02-01
Completion
2022-02-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02898090 on ClinicalTrials.gov